✕
Topic Paragraphs
Rare Disease Framework Initiative Launched

Rare Disease Framework Initiative Launched

New FDA initiative reimagines the agency’s approach to creating a customized framework for rare disease drug development that considers the nuances of a specific disease, patient needs, product type, and attainable evidence.
 

Featured Topics

Recalls
Report a Problem
Warning Letters
Consumer Updates
483s
EUAs
510Ks
Guidance Documents
Drug Databases
Import Program

FDA in Action

Image
Transparency Makes Modern Regulatory Science Stronger — FDA’s Transparency Roadmap
Image
FDA Approves First Heart Valve Designed to Grow with Children
Image
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
Image
Supporting and Strengthening Domestic Drug Manufacturing
Image
The FDA at 120: A Long, Distinguished History Protecting Americans
Image
Accelerating and Modernizing Early and Late-Stage Clinical Development
Image
Year 1 Goals in Reducing Animal Testing in Drug Development
Image
Results from Largest-Ever Testing of Infant Formula in the U.S.
Image
FDA PreCheck Pilot Program: Strengthening Domestic Pharmaceutical Manufacturing

Press Announcements

October 14, 2026

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer 

October 14, 2026

FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development

October 05, 2026

FDA Seeks Public Input to Support Ibogaine Research

Products We Regulate

Image
Food
Image
Drugs
Image
Medical Devices
Image
Radiation-Emitting Products
Image
Vaccines, Blood, and Biologics
Image
Animal and Veterinary
Image
Cosmetics
Image
Tobacco Products
Back to Top